Monoammonium Glycyrrhizinate/Cysteine Hydrochloride

甘草酸单铵/盐酸半胱氨酸

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMonoammonium Glycyrrhizinate/Cysteine Hydrochloride
Drug Alias Name甘草酸单铵半胱氨酸氯化钠注射液
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHepatitis, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHepatitis, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A